CRISPR
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade CRISPR 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CRSP
CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA.
CEOSamarth Kulkarni
CEOSamarth Kulkarni
Employees393
Employees393
HeadquartersZug, Zug
HeadquartersZug, Zug
Founded2013
Founded2013
Employees393
Employees393
CRSP Key Statistics
Market cap3.17B
Market cap3.17B
Price-Earnings ratio-8.49
Price-Earnings ratio-8.49
Dividend yield—
Dividend yield—
Average volume1.56M
Average volume1.56M
High today$38.20
High today$38.20
Low today$36.80
Low today$36.80
Open price$37.99
Open price$37.99
Volume1.60M
Volume1.60M
52 Week high$68.39
52 Week high$68.39
52 Week low$36.52
52 Week low$36.52
CRSP News
TipRanks 5d
CRISPR Therapeutics COO Julianne Bruno ResignsAn announcement from Crispr Therapeutics AG ( (CRSP) ) is now available. On March 24, 2025, Julianne Bruno, the Chief Operating Officer of CRISPR Therapeutics,...
Analyst ratings
55%
of 31 ratingsBuy
54.8%
Hold
41.9%
Sell
3.2%